Lamotrigin Dura

Lamotrigine, the active ingredient in Lamotrigin Dura, is an Anticonvulsant presented as a tablet for oral use. It treats focal seizures, generalized tonic‑clonic seizures, primary generalized seizures, and is used as maintenance therapy for bipolar disorder in appropriate patients. It is indicated for patients with epilepsy and for mood stabilization in bipolar disorder, and is administered under medical supervision. GNH USA supplies Lamotrigin Dura as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Lamotrigine is used in the management of several seizure types and as a mood stabilizer in bipolar disorder. Focal seizures: reduces frequency and severity of seizures originating in a specific brain region. Generalized tonic‑clonic seizures: helps prevent convulsive episodes affecting the whole brain. Primary generalized seizures: decreases occurrence of absence and myoclonic seizures. Bipolar disorder (maintenance): stabilizes mood and reduces risk of manic or depressive episodes. Adjunct therapy for refractory epilepsy: may be combined with other antiepileptic drugs to improve control.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate cranial pain. - Nausea: feeling of stomach upset, sometimes with vomiting. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement. - Aseptic meningitis: inflammation of the meninges presenting with fever, neck stiffness, and headache. - Blood dyscrasias: rare cases of agranulocytosis or aplastic anemia.

When prescribing lamotrigine, clinicians should consider several safety measures to minimize risks. Start low, increase slowly: titrate dose gradually to reduce rash risk. Monitor skin reactions: discontinue immediately if a serious rash develops. Assess hepatic function: adjust dosing in patients with liver impairment. Avoid abrupt discontinuation: taper to prevent seizure worsening. Pregnancy counseling: discuss potential risks and benefits with women of childbearing potential. Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels; co‑administration requires substantial dose reduction. - Carbamazepine, phenytoin, phenobarbital: induce metabolism and can lower lamotrigine concentrations, risking loss of seizure control.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce lamotrigine levels, requiring possible dose adjustment. - Serotonergic agents (e.g., SSRIs, SNRIs): may increase risk of serotonin syndrome, monitor for symptoms. - Other antiepileptic drugs: combined therapy may require therapeutic drug monitoring.